Brief: Qualigen Therapeutics gets Nasdaq notice on non-compliance with listing rule
22/10/2024 23:00
Oct 22 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS INC: ON OCT 18 CO RECEIVED A NASDAQ
NOTICE
OF NON-COMPLIANCE WITH NASDAQ LISTING RULE 5605
Source text for Eikon: ID:n0001493152-24-042068
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise